Unplanned analysis showed ORR of 18 % ( five of 28 ) versus 0 % ( 0 of 11 ) in patients with triple-negative breast cancer ( TNBC ) , and 40 % ( four of 10 ) versus 0 % ( zero of six ) in gpNMB-overexpressing TNBC .